Schizophrenia can be a commonly misunderstood illness, in part due to a great deal of misinformation, which can lead to potentially damaging stigma for the estimated 2.4 million adults in the United ...

An association between oral microbiota and cognitive performance in schizophrenia has been reported by researchers at Science ...

Please provide your email address to receive an email when new articles are posted on . Cobenfy is the first antipsychotic medication to treat schizophrenia by targeting cholinergic receptors. The ...

Teva’s presentation of findings from six schizophrenia studies at Psych Congress 2024 highlights its commitment to finding new innovations in neuroscience Data show TEV-'749 drug delivery technology ...

The term "schizophrenia" was unclear in meaning from its beginning and has remained unclear ever since. It is long past time to replace it with better alternatives.

New research suggests that auditory hallucinations in schizophrenia may come from a brain glitch that confuses inner thoughts ...

How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

Hearing imaginary voices is a common but mysterious feature of schizophrenia spectrum disorders. Up to 80 percent of people with these conditions experience auditory hallucinations, hearing speech or ...

Schizophrenia has long been one of medicine’s most puzzling conditions, with genetics offering tantalizing clues but an ...